FDA Adverse Event Injury Summary report: N

PROMETRA II PROGRAMMABLE PUMP

MDR report key: 24189755 · Received January 27, 2026

Report

Report Number
3030198397-2026-00002
Event Type
Injury
Date Received
January 27, 2026
Date of Event
December 17, 2025
Manufacturer
INFUSYN THERAPEUTICS, LLC
Product Code
LKK
UDI-DI
00810335020228
PMA / PMN Number
P080012
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A REVIEW OF THE DEVICE HISTORY RECORD, DID NOT IDENTIFY ANY NON-CONFORMANCES, ISSUES OR CAPAS ASSOCIATED WITH PUMP FUNCTION. DEVICE HAS NOT YET BEEN RETURNED FOR ADDITIONAL EVALUATION AND INVESTIGATION. AS ADDITIONAL PHYSICAL INVESTIGATION WAS NOT PERFORMED ON THE DEVICE, A DEFINITIVE ROOT CAUSE COULD NOT BE DETERMINED FOR THE ALLEGED ISSUE. THIS COMPLAINT WILL BE CLOSED AND RE-OPENED IF/WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE. INTERNAL COMPLAINT NUMBER: (B)(4).

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL CONTACTED THE SENIOR CLINICAL ENGINEER (SCE) REGARDING A PATIENT'S PUMP THAT WAS SHOWING SLIGHTLY MORE MEDICATION LEFT IN THE PUMP THAN EXPECTED. THE NURSE STATED THAT THE PATIENT WAS NOT ALLEGING ANY NEGATIVE SYMPTOMS, BUT THAT THE PUMP IS SCHEDULED FOR EXPLANT ON (B)(6) 2025, SINCE THERE WERE A COUPLE MORE MLS OF MEDICATION PULLED OUT THAN WAS EXPECTED. SCE WALKED THE REPORTER THROUGH SEVERAL TROUBLESHOOTING STEPS, INCLUDING A DYE STUDY TO DETERMINE IF THERE WAS AN OCCLUSION OR A KINK. HOWEVER, THE PHYSICIAN ASSOCIATED WITH THE CASE REPORTED THAT THAT WOULD NEED TO BE PERFORMED BY THE MANAGING PHYSICIAN AND AS THE SURGEON, THEY WILL ONLY DO EITHER A REVISION OR AN EXPLANT. THE EXPLANT IS SCHEDULED FOR (B)(6) 2025.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
254128 PROMETRA II PROGRAMMABLE PUMP Pump, infusion, implanted, programmable LKK INFUSYN THERAPEUTICS, LLC 13827 23201 00810335020228

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention